Disruption of MEK/ERK/c-Myc signaling radiosensitizes prostate cancer cells in vitro and in vivo
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Disruption of MEK/ERK/c-Myc signaling radiosensitizes prostate cancer cells in vitro and in vivo
Authors
Keywords
Prostate cancer, C-Myc, ERKs, U0126, Radiotherapy, Radioresistance
Journal
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-06-29
DOI
10.1007/s00432-018-2696-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells
- (2017) Francesca Megiorni et al. Journal of Hematology & Oncology
- Therapeutic Approaches Targeting MYC-Driven Prostate Cancer
- (2017) Richard Rebello et al. Genes
- KI67 and DLX2 predict increased risk of metastasis formation in prostate cancer–a targeted molecular approach
- (2016) William JF Green et al. BRITISH JOURNAL OF CANCER
- Key role of MEK/ERK pathway in sustaining tumorigenicity and in vitro radioresistance of embryonal rhabdomyosarcoma stem-like cell population
- (2016) Carmela Ciccarelli et al. Molecular Cancer
- c-Myc Sustains Transformed Phenotype and Promotes Radioresistance of Embryonal Rhabdomyosarcoma Cell Lines
- (2016) G. L. Gravina et al. RADIATION RESEARCH
- Ki-67 is required for maintenance of cancer stem cells but not cell proliferation
- (2016) Justin Cidado et al. Oncotarget
- Broad targeting of angiogenesis for cancer prevention and therapy
- (2015) Zongwei Wang et al. SEMINARS IN CANCER BIOLOGY
- Tadalafil modulates aromatase activity and androgen receptor expression in a human osteoblastic cell in vitro model
- (2015) A. Aversa et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Progress and controversies: Radiation therapy for prostate cancer
- (2014) Neil E. Martin et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Radiotherapy-induced plasticity of prostate cancer mobilizes stem-like non-adherent, Erk signaling-dependent cells
- (2014) L Kyjacova et al. CELL DEATH AND DIFFERENTIATION
- Hypoxia sustains glioblastoma radioresistance through ERKs/DNA-PKcs/HIF-1α functional interplay
- (2014) FRANCESCO MARAMPON et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Discovery of a Selective Irreversible BMX Inhibitor for Prostate Cancer
- (2013) Feiyang Liu et al. ACS Chemical Biology
- Trametinib: First Global Approval
- (2013) Cameron J. M. Wright et al. DRUGS
- PXD101 potentiates hormonal therapy and prevents the onset of castration-resistant phenotype modulating androgen receptor, HSP90, and CRM1 in preclinical models of prostate cancer
- (2013) Giovanni Luca Gravina et al. ENDOCRINE-RELATED CANCER
- Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
- (2013) J. Ferlay et al. EUROPEAN JOURNAL OF CANCER
- Close correlation between MEK/ERK and Aurora-B signaling pathways in sustaining tumorigenic potential and radioresistance of gynecological cancer cell lines
- (2013) FRANCESCO MARAMPON et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Copy number alterations of c-MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapy
- (2012) Gaetano Zafarana et al. CANCER
- Total ERK1/2 activity regulates cell proliferation
- (2011) Renaud Lefloch et al. CELL CYCLE
- Oncogene addiction as a foundational rationale for targeted anti-cancer therapy: promises and perils
- (2011) Davide Torti et al. EMBO Molecular Medicine
- MEK/ERK Inhibitor U0126 Increases the Radiosensitivity of Rhabdomyosarcoma Cells In vitro and In vivo by Downregulating Growth and DNA Repair Signals
- (2011) F. Marampon et al. MOLECULAR CANCER THERAPEUTICS
- Compensatory Upregulation of Tyrosine Kinase Etk/BMX in Response to Androgen Deprivation Promotes Castration-Resistant Growth of Prostate Cancer Cells
- (2010) B. Dai et al. CANCER RESEARCH
- The role of hypoxia and acidosis in promoting metastasis and resistance to chemotherapy
- (2009) Katie DeClerck Frontiers in Bioscience-Landmark
- Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis
- (2008) Bora Gurel et al. MODERN PATHOLOGY
- Modelling Myc inhibition as a cancer therapy
- (2008) Laura Soucek et al. NATURE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started